You are here: All Products > Sperogenix Acquires China Rights to Rare Disease Candidate in $78 Million Deal
Sperogenix Acquires China Rights to Rare Disease Candidate in $78 Million Deal
You are here: All Products > Sperogenix Acquires China Rights to Rare Disease Candidate in $78 Million Deal